The endorsement of WTO and IPR by the Indian government in the early 90's has made a significant impact on the growth and fortunes of the pharmaceutical industry. The recognition of international product patents is now expected to spur pharmaceutical research in this country to supplement global efforts for searching new molecules for unmet medical needs and to develop generic products to reduce healthcare costs.
The last five years have also witnessed a tremendous interest and activity in the area of clinical research services in India. Nascent for years, it is now expected to be a billion dollar industry by 2010 - thanks largely to a huge medical infrastructure, availability of large banks of treatment-naïve patients in a variety of diseases, increasing GCP awareness among clinical investigators, fluency in English language and cost effectiveness of Indian operations. So, while India builds up on the potential of being an attractive clinical research destination, it is important that the emerging professional contract research organizations (CROs) maintain high standards of ethics and GCP compliance to support this endeavor. MED DEVICES is one such committed organization.
In India, health services are provided by the government through publicly financed and managed curative and preventive health services from the primary to the tertiary level. These services, accounting for about 18 percent of the overall health spending and 0.9 percent of the GDP, are provided free of cost to the patients. A fee-levying private sector that plays a dominant role in the provision of individual curative care through ambulatory services coexists with public health care. It accounts for about 82 percent of the overall health expenditure and 4.2 percent of the GDP.
INDIA's MEDICAL INFRASTRUCTURE
Hospitals 14,000
Doctors 500,000
Hospital beds 700,000 (85% urban)
Medical colleges 162
Medical graduates 17,000/year
The endorsement of WTO and IPR by the Indian government in the early 90's has made a significant impact on the growth and fortunes of the pharmaceutical industry. The recognition of international product patents is now expected to spur pharmaceutical research in this country to supplement global efforts for searching new molecules for unmet medical needs and to develop generic products to reduce healthcare costs.
The last five years have also witnessed a tremendous interest and activity in the area of clinical research services in India. Nascent for years, it is now expected to be a billion dollar industry by 2010 - thanks largely to a huge medical infrastructure, availability of large banks of treatment-naïve patients in a variety of diseases, increasing GCP awareness among clinical investigators, fluency in English language and cost effectiveness of Indian operations. So, while India builds up on the potential of being an attractive clinical research destination, it is important that the emerging professional contract research organizations (CROs) maintain high standards of ethics and GCP compliance to support this endeavor. MED DEVICES is one such committed organization.
In India, health services are provided by the government through publicly financed and managed curative and preventive health services from the primary to the tertiary level. These services, accounting for about 18 percent of the overall health spending and 0.9 percent of the GDP, are provided free of cost to the patients. A fee-levying private sector that plays a dominant role in the provision of individual curative care through ambulatory services coexists with public health care. It accounts for about 82 percent of the overall health expenditure and 4.2 percent of the GDP.
INDIA's MEDICAL INFRASTRUCTURE
Hospitals 14,000
Doctors 500,000
Hospital beds 700,000 (85% urban)
Medical colleges 162
Medical graduates 17,000/year
|
